NovaCord is brought to you by Fortis Healthcare in collaboration with TotipotentRX, a U.S. based cellular therapy company. The combination of Fortis' clinical expertise and TotipotentRX's stem cell experience has resulted in the most advanced regenerative medicine clinical program in Asia.
Fortis Healthcare (India) Ltd, India's fastest growing hospital network, formed a collaboration
in March 2011 with TotipotentRX Cell Therapy Pvt. Ltd
(formerly Thermogenesis), a leading provider of cutting-edge technologies in the stem cell and regenerative medicine market, to set up centres of excellence offering cellular therapies and stem cell clinical trials, across select Fortis hospitals.